Please assess the completion status of the following clinical trial:

Trial Title: A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Voluntary signature of the Informed Consent~2. Axial low back pain for a minimum of 3 months~3. Male or female ages 18-75~4. Recent MRI (within last 6 months) consistent Kader grade 2 or 3 multifidus atrophy at 1 or 2 levels~5. Is independent, ambulatory, and can comply with all post-operative evaluations and visits~Exclusion Criteria:~1. Mild multifidus atrophy Kader grade 1~2. Multifidus atrophy at more than 2 levels~3. Symptomatic spinal stenosis (e.g. pseudoclaudication with moderate or severe MRI findings of stenosis)~4. Radicular symptoms (e.g. lower extremity radiating numbness, tingling, paresthesia, etc)~5. Fracture, previous spine surgery, neuromuscular disease of the trunk, malignancy, infection, or pregnancy~6. Radiofrequency ablation within the previous 12 months~7. Corticosteroid injection (epidural or facet) within the past 3 months~8. Contraindications for MRI~9. Condition represents a worker's compensation case~10. Currently involved in a health-related litigation procedure~11. Bleeding disorders~12. Allergy or intolerance to study medication~13. Use of chronic opioid~14. Documented history of drug abuse within six months of treatment~15. Any other condition, that in the opinion of the investigator, that would preclude the patient from enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- PPP treatment (Type: EXPERIMENTAL): Platelet Poor Plasma (PPP) into the multifidus on each side and at each level 1 time per week for 6 weeks (series of 6 injections)
- PRP treatment (Type: EXPERIMENTAL): 5x concentration Platelet Rich Plasma (PRP) injected into the multifidus on each side and at each level 1 time per week for 6 weeks (series of 6 injections)
- PRP and PL Combo treatment (Type: EXPERIMENTAL): 5x concentration PRP injected into the multifidus, along with a facet joint injection with 14x PRP into each joint and capsule, and transforaminal epidural injection with of 3x concentrated platelet lysate (PL) and 0.5% ropivacaine on each side and at each level 1 time every 2 weeks for 6 weeks total (series of 3 injections)

Based on this trial design, predict the completion outcome and termination type (if applicable).